Wikidata

(Q33374513)

English

Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group

scientific article

In more languages

Statements

title
Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
main subject
Canada
0 references
author name string
Christine I Chen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
C Tom Kouroukis
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
Darrell White
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
Michael Voralia
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
A Keith Stewart
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
John J Wright
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
Elizabeth Eisenhauer
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017
page(s)
1570-1575
1 reference
stated in
Europe PubMed Central
PubMed ID
17353550
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33374513&oldid=1992802786"